Use access key #2 to skip to page content.
$6.77 -0.65 (-8.76%)
10/6/2008 4:00 PM

Cardiome Pharma Corp. (USA) (CRME)

CAPS Rating:
**

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

View All Commentary (CRME)

Recs

0

Avatar JonAtkins57 (< 20) Submitted: 6/30/08 1:50 PM : Underperform Start Price: $8.86 CRME Score: -3.36

Market Cap > 100M and < 1B
Gross Margin % < -10
Net Profit Margin % < -10
EPS < -1

Report this Post Replies: 0 | Reply

Featured Broker Partners